Trials are beginning to confirm that digital endpoints can produce the kind of reliable, real-world data sponsors need.

A few months back, good news hit the multiple myeloma community: the U.S. Food & Drug Administration voted to accept a new endpoint — MRD, or measurable residual disease — for accelerated approval of ...

At nearly every major industry conference — from HLTH to CNS Summit, Exponential Medicine, and Rock Health Summit — speakers are talking about the benefits of decentralized clinical trials and digital ...

The US Food and Drug Administration has issued new guidance for industry about designing and interpreting clinical trials that use multiple endpoints, all to avoid making the types of mistakes than ...